Aggressive B-Cell Lymphomas: Clinical Application of New Advances in Community Practice

A series of live interactive workshops featuring expert perspectives on managing patients with aggressive B-cell lymphomas. Live simulcasts of 3 workshops will be available as well as a downloadable slideset treatment summary resource guides and an on-demand webcast covering these important topics.

Share

Program Content

Aggressive B-Cell Lympomas Slides
Aggressive B-Cell Lymphomas: Clinical Application of New Advances in Community Practice
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: March 08, 2022

Expires: March 07, 2023

View Activity
IMiDs and ICIs for B-Cell Lymphomas
Immunomodulatory Agents and Immune Checkpoint Inhibitors in B-Cell Lymphomas: A Summary Resource
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: March 22, 2022

Expires: March 21, 2023

View Activity
Ab-Based Tx in B-cell Lymphomas
Antibody-Based Therapies for B-Cell Lymphomas: A Summary Resource
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: March 22, 2022

Expires: March 21, 2023

View Activity
Bispecific Abs in B-Cell Lymphomas
Bispecific Antibodies in B-Cell Lymphomas: A Summary Resource
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: March 22, 2022

Expires: March 21, 2023

View Activity
CAR T-cells for B-Cell Lymphomas
CAR T-cell Therapy in B-Cell Lymphomas: A Summary Resource
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: March 22, 2022

Expires: March 21, 2023

View Activity
ADCs for B-Cell Lymphoma
Antibody–Drug Conjugates for B-Cell Lymphomas: A Summary Resource
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: March 22, 2022

Expires: March 21, 2023

View Activity
BTKi for B-Cell Lymphomas
BTK Inhibitors for B-Cell Lymphomas: A Summary Resource
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: March 22, 2022

Expires: March 21, 2023

View Activity
XPO1 Inhibitors for B-Cell Lymphomas
XPO1 and Nuclear Export Inhibitors in B-Cell Lymphomas: A Summary Resource
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: March 22, 2022

Expires: March 21, 2023

View Activity
B-Cell Lymphomas: New Adv
Aggressive B-Cell Lymphomas: Clinical Application of New Advances in Community Practice
Multimedia
Congratulations: You achieved a completion on 04/09/2022

Released: November 16, 2022

Expires: November 15, 2023

View Activity

Faculty

cover img faculity

Jeremy S. Abramson, MD, MMSc

Associate Professor
Department of Medicine
Harvard Medical School
Director, Center for Lymphoma
Massachusetts General Hospital
Boston, Massachusetts

cover img faculity

Ian W. Flinn, MD, PhD

Director, Lymphoma Research 
Sarah Cannon Research Institute
Tennessee Oncology
Nashville, Tennessee

cover img faculity

Satish Shanbhag, MD

Hematologist/Oncologist
Cancer Specialists of North Florida

Provided by

ProCE Banner

Supporters

Supported by educational grants from

Bristol Myers Squibb

Genentech, a member of the Roche Group

Genmab US Inc and AbbVie

Karyopharm Therapeutics

Novartis Pharmaceuticals Corporation